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Reduced physical activity in children and
adolescents with Juvenile Idiopathic
Arthritis despite satisfactory control of
inflammation
Anna-Helene Bohr1*, Susan Nielsen1, Klaus Müller2, Freddy Karup Pedersen1 and Lars Bo Andersen3,4
Abstract
Background: Vascular health is of concern in patients with Juvenile Idiopathic Arthritis (JIA) since Rheumatoid
Arthritis (RA) epidemiologically has a well-described association with premature development of atherosclerosis.
Chronic inflammation with persisting systemic circulating inflammatory proteins may be a cause of vascular damage,
but general physical inactivity could be an important contributor. Pain and fatigue are common complaints in patients
with JIA and may well lead to an inactive sedentary lifestyle. For this reason we assessed the physical activity (PA)
objectively in patients with moderate to severe Juvenile Idiopathic Arthritis (JIA) in comparison with gender and age
matched healthy schoolchildren, and looked for associations between PA and features of JIA.
Methods: One hundred thirty-three patients, 7–20 years of age, participated. Disease activity, disability, functional
ability, and pain were assessed and PA was measured by accelerometry through 7 days and compared to PA in
age- and gender-matched healthy schoolchildren.
Results: We found a significantly lower level of PA in patients compared to gender- and age-matched healthy
schoolchildren both in average activity (counts per minute, cpm) (475.6 vs. 522.7, p = 0.0000018) and in minutes per
day spent with cpm >1500 (67.9 vs. 76.4, p = 0.0000014), with cpm >2000 (moderate physical activity) (48.4 vs. 52.8,
p = 0.0001, and with cpm >3000 (high physical activity) (24.7 vs. 26.5, p = 0.00015). A negative association (β = −0.213,
p = 0.014) between active disease in weight bearing joints and high physical activity remained the only significant
association between disease related factors and PA. Of the girls 19 % and of the boys 45 % (vs. 39 % and 61 % in the
reference group) met standards set by Danish Health Authorities for daily PA in childhood.
Conclusion: Children and adolescents with JIA are less physically active than their healthy peers and less active than
recommended for general health by the Danish Health Authorities. This is not explained by pain or objective signs of
inflammation. When inflammation has been curbed, restoration of an active healthy lifestyle should be highly
prioritized.
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Background
Juvenile Idiopathic Arthritis (JIA) is the most common
rheumatic disease of childhood with an annual incidence
in the Western world of 16–150 per 100.000 children.
During the last few decades, advances in medical treat-
ment have changed the prognosis profoundly for these
patients, and erosive arthritis resulting in functional dis-
ability during childhood is now rare. Spontaneous remis-
sion occurs, but 41–78 % of patients require continuous
or recurrent treatment in adulthood, polyarthritis carry-
ing the worst prognosis [1–4].
Rheumatoid Arthritis (RA) is epidemiologically associ-
ated with premature development of cardiovascular disease
(CVD) and shortened lifespan. This has led to investiga-
tions of the vascular health in patients with JIA; indeed
one finds arterial endothelial thickening, a preclinical sign
of atherosclerosis that may develop into accelerated clinic-
ally important arteriosclerosis in adulthood [5–7]. Chronic
inflammation with persisting systemic circulating inflam-
matory proteins could be a cause of vascular damage, but
general physical inactivity in childhood is associated with
well-known risk factors for premature development of car-
diovascular disease [8] and could be an important con-
tributor. Pain and fatigue are common complaints in
patients with JIA and may well lead to an inactive lifestyle.
A sedentary lifestyle may also be harmful to the general
development of the cardio-respiratory system and prevent
a healthy development of the musculoskeletal system with
the fine-tuning of motor skills, developing by usage.
Moreover, an inactive lifestyle may be associated with so-
cial isolation, which may be a serious threat to normal
mental development in childhood and adolescence.
Physical inactivity may thus impose an additional bur-
den on the health of patients with JIA.
The primary aim of the present cross-sectional study
was to assess the pattern of physical activity (PA) in chil-
dren and adolescents with moderate to severe JIA, testing
the hypothesis that patients with JIA are less physically ac-
tive and possibly spend more time with sedentary activ-
ities than their healthy peers. Increased knowledge on this
could be important for attention to exercise as part of the
treatment for JIA. As self-reporting of physical activity
(PA) is known to be unreliable [9, 10], we chose to moni-
tor PA objectively by accelerometry.
Secondarily we wanted to look for a possible associ-
ation between PA and disease activity, disability, pain,
functional ability, JIA subgrouping, duration of symp-
toms, medication, and body mass.
Methods
This is a population based descriptive cross-sectional
study of objectively measured PA in patients with mod-
erate to severe JIA, compared to age- and gender-
matched healthy Danish schoolchildren.
The patients, markers of disease activity, and disability,
signs of functional ability, and accelerometer measure-
ment are described below in detail.
Data were collected throughout a period of two years
from May 2011, covering different seasons and different
times of the day for examinations. International recom-
mendations for treatment of JIA remained unchanged
during this period.
Ethics
Ethics approval was obtained from The Committee on
Biomedical Research Ethics in the Region of Sjaelland
(SJ-220) and written information and accept obtained
from patients or guardians according to the patients’ age.
Patients
Children and adolescents with moderate to severe JIA,
followed at a population based center for pediatric
rheumatology, were invited to participate. All the pa-
tients with JIA living in the eastern part of Denmark
(with a total population of 2.6 million) were seen at this
clinic. Inclusion criteria were age between 7 and 20 years
and JIA of a severity that necessitated treatment with
Disease Modifying Medication (DMARD), either metho-
trexate (MTX) or biologics: TNF-α- or IL-6-inhibitors or
T-cell co-stimulation inhibitor CTLA-4-Ig (Abatacept),
or a need for frequently repeated intra-articular injec-
tions of corticosteroid. No one had other significant
chronic conditions than JIA.
Of 260 eligible patients, 166 accepted to participate in
the whole investigation including monitoring with accel-
erometer, and of these, 133 patients returned accelerom-
eter monitoring results of a sufficient quality for
evaluation (Fig. 1).
The group of patients included in the final analyses
(133 patients) is described by gender, age, weight, height,
body mass index (BMI), JIA subgroup, treatment, and
disease duration; number of patients in clinical remis-
sion with or without medication is specified (Table 1).
Reference data
Data on physical activity, measured by accelerometry, in
healthy Danish schoolchildren, collected in The Euro-
pean Youth Heart Study (EYHS) [10, 11] and in The
Copenhagen School Child Intervention Study (CoSCIS)
[12] looking at risk factors for accelerated development
of atherosclerosis, served as gender- and age-matched
comparisons; in total 1696 measurements, 862 boys and
834 girls, all fulfilling standard criteria for validity given
below. Every patient is compared to a group of healthy
peers of same age +/− 1.5 years and of same gender.
Only data on Danish schoolchildren are used for com-
parison in the present study, as national cultural differ-
ences could be of importance.
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The data on healthy schoolchildren have formed the
basis for The Danish Health Authorities’ guidelines for
daily PA in childhood [13].
Clinical assessment of disease activity
All participants, diagnostically sub-grouped in accord-
ance with ILAR criteria [14], were assessed clinically by
a pediatrician experienced in pediatric rheumatology
who did not take part in the investigation (Table 2). The
participants were all seen as part of a routine control in
the outpatient clinic; no one was seen because of acute
disease flare. Actual disease activity was evaluated by a
composite score, Juvenile Arthritis Disease Activity
Score (JADAS) [15, 16], combining: i) number of joints
with active inflammation (maximum 27 joints), ii) global
260 patients fulfilled the inclusion criteria
50declined to participate
44 accepted clinical examination and blood tests 
but declined accelerometer monitoring
133 returned satisfactory accelerometer  
measurements for assessment of physical activity
166 accepted to participate fully
Fig. 1 Number of patients entered in final analyses
Table 1 Descriptive characteristics of the patients with valid
accelerometer data
Total number 133
Females/males 99 (74 %)/34 (26 %)
Age (years) Mean 14.0 (SD 3.37)
Height (m) Mean 1.58 (SD 0.14)
Weight (kg) Mean 51.2 (SD 15.2)
BMI (kg/m2) Mean 20.1 (SD 3.93)
JIA subgroup:
Systemic 4 (3 %)
Persisting Oligoarticular 38 (29 %)
Polyarticular, RF negative 41 (31 %)
Polyarticular, RF positive 3 (2 %)
Psoriasis associated 15 (11 %)
Enthesitis associated 31 (23 %)
Undifferentiated 1 (1 %)
Treatment:
Methotrexate 31 (23 %)
Biologics 86 (65 %)
Only intra-articular injections 11 (8 %)
None 5 (4 %)
Disease durationa in years Mean 5.72 (SD 3.43)
Remission, still on medication 20 (15 %)
Remission, off medication 3 (2 %)
Summary statistics: Number with percentage in brackets, mean with SD in
brackets, and median with range in brackets
BMI body mass index, JIA juvenile Idiopathic Arthritis, RF reumafactor
aDisease duration = duration of symptoms
Table 2 Markers of disease activity at the time of accelerometry
Number of active joints Mean 1.29 (SD 2.64) (range 0–24)
Physician global VAS (0–10) Mean 1.29 (SD 2.64) Median 1.0
(range 0–6.5)
Patient/parent global VAS (0–10) Mean 1.6 (SD 2.0) Median 0.8
(range 0–8.2)
Truncated ESR (tESR) (mm/hour) Mean 0,11 (SD 0,47)
High sensitivity CRP (mg/l) Mean 1.92 (SD 3.86)
JADAS 27 (0–57)a Mean 4.1 (SD 4.6) Median 3.1
(range 0–27)
Number of active weight
bearing joints
Mean 0.9 (SD 1.3)
Tendinitis and/or entesitis
(yes/no)
31 (23.3 %)
Patient Pain VAS (0–10) Mean 2.9 (SD 2,7) Median 2.2
(range 0–10)
CHAQ (0–3) Mean 0.4 (SD 0.5) Median 0.3 (ran
aJADAS 27 (0–57): a composite score of: number of joints with active disease
(max 27), Physician global VAS, patient/parent global VAS and truncated
ESR (tESR)
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disease scoring by physician, iii) global disease scoring
by patient or parent according to age, and iv) truncated
erythrocyte sedimentation rate (tESR). JADAS 27 is mea-
sured on a scale from 0 to 57.
In addition was noted the number of weight bearing
joints with active inflammation. Also the occurrence of
tendinitis and/or enthesitis was noted, as JADAS may
have limited construct validity for psoriasis associated
arthritis and enthesitis associated arthritis.
Global disease scoring was carried out by the physician
on a Visual Analog Scale (VAS) from 0 (no sign of dis-
ease) to 10 (maximal disease burden) and the patient, or
the parents according to age, marking on a VAS from 0
to10 how well the patient was doing considering having
JIA, ten being worst. Remission was assessed according
to Wallace criteria [17]. Disability was assessed by meas-
uring limits of articular motion, and functional ability by
the Danish version of Childhood Health Assessment
Questionnaire (CHAQ) [18, 19]. In addition the child
was asked to mark on a VAS (0–10) the level of pain
during the last week, reflecting persistent pain.
Special charts were supplied for the clinical assess-
ment. If the charts were insufficiently filled in, the miss-
ing information was found in the patient record for the
actual visit in the outpatient clinic.
Markers of inflammation
Besides the clinical assessment and measurement of
hemoglobin, were measured numbers of neutrophils and
thrombocytes, IgG, high sensitivity C-reactive protein
(hsCRP) and erythrocyte sedimentation rate (ESR). ESR
was truncated (tESR) according to the formula given by
Consolaro et al. [15]: after converting ESR values of less
than 20 mm/hour to 0 and ESR above 120 to 120, tESR
was calculated as (ESR (mm/hour) − 20) / 10.
Treatment
All patients or their parents were asked about the actual
medication and the date for the last administration. The
given information was in accordance with registered
information.
Anthropometry
Weight was measured with light clothing to the nearest
0.1 kg and height without shoes to the nearest 0.5 cm.
BMI was calculated as weight/squared height.
Accelerometry
An accelerometer, ActiGraph model GT1M (ActiGraph
Inc., Pensacola, FL, USA), was used for measurement of
volume and pattern of physical activity. The accelerom-
eter measures accelerations in vertical movements with
a filter for separating mere vibrations from movements.
Accelerometers have now been used for more than a
decade and have been found reliable for assessment of
physical activity by comparison with energy expenditure
[9]. The accelerometer collects data continuously, which
in our investigation were set to be summed up in epochs
of 5 s to capture the changing pattern of movement seen
in children as compared to adults. The raw data were
converted by the ActiGraph software to i) mean counts
per minute (cpm), a measure of the total physical activity
during total time of measurement, and ii) minutes per
day spent on activity with more than 1500 cpm), iii)
moderate physical activity (more than 2000 cpm, MPA),
and iv) high physical activity (more than 3000 cpm,
HPA), cut-points routinely used by others.
The accelerometer is a small, portable device fastened
with an elastic band around the waist, the center of the
body. In the study it was worn for seven days during all
wake hours except when swimming or bathing, as the
device is not waterproof. Time during the day spent
without the device was noted in a small diary with infor-
mation about the reason. Also time spent on horseback
riding and cycling was noted, as accelerometry does not
capture these physical activities accurately [20]. The ac-
celerometer monitoring began the day after the clinical
assessment in the outpatient clinic.
Adhering to the standards used in EYHS and CoSCIS
for processing the accelerometer-data, only data col-
lected during a minimum of 10 h per day for three days
were considered reliable in assessing the physical activ-
ity. Periods of more than 10 min of zero count were
considered as periods of “non-wear”.
Statistical analyses
Summary statistics, mean and SD, median and range, or
numbers with percentage, were chosen as descriptive
measures.
The distribution of the level of physical activity in pa-
tients with JIA is compared to matched healthy school-
children by Related-Samples Wilcoxon Signed Rank
Test, after log10 transformation because of a skewed dis-
tribution. Every patient is compared to a group of same
age +/− 1.5 years and of same gender.
PA variables were log10 transformed because of a
skewed distribution, and the dependence on disease re-
lated factors was tested by analysis of variance (one-way
ANOVA), linear regression or by rank correlations/
Spearman’s rho (non-parametric) or t-test as appropriate
and specified.
Significance (p) is given as two-tailed and α selected
as 0.05.
All analyses were done in SPSS19 or in Excel 2010.
Results
The inclusion criteria were fulfilled by 260 patients, 50
patients refused to participate and 44 accepted clinical
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examination and blood tests but declined accelerometer
monitoring. 166 patients accepted to participate fully
but only 133 returned satisfactory accelerometer mea-
surements for assessment of physical activity. Data are
presented in Fig. 1.
Descriptive characteristics of the patients with valid
accelerometer data are given in Table 1.
The group of eligible patients who chose not to par-
ticipate (50 patients), or who returned no (44 patients)
or unusable (33 patients) accelerometer data, were com-
parable to the group of fully participating patients (in
total 133) with regards to distribution of gender, age,
diagnostic subtype, and BMI. However, a significant dif-
ference (p = 0.001) was found in disease duration be-
tween the fully participating patients (mean 5.7 years,
SD 3.5) and those not willing to wear the accelerometer
(mean 7.3 years, SD 4.2). No markers of disease activity,
described in Table 2, differed significantly between those
participating fully in the program and those who
returned unusable accelerometer data or only accepted
blood tests and clinical examination.
Comparison of the distributions of the physical activity
in patients with JIA and gender- and age-matched healthy
schoolchildren by The Related-Samples Wilcoxon Signed
Rank Test (2-tailed, α = 0.05) shows a significant differ-
ence both in average activity (cpm) and in the level of ac-
tivity (minutes per day with cpm >1500 or >2000 (MPA)
or >3000 (HPA)). Results are shown in Table 3.
As seen in Table 4 only a relatively low percentage of
participating patients fulfilled The Danish Health Au-
thorities’ guidelines [13] for daily PA in childhood of
more than 60 min a day of moderate physical activity
(MPA) compared to healthy schoolchildren; in boys
45 % vs. 61 %, in girls 19 % vs. 39 %.
A negative association (β = − 0.213, p = 0.014) was
found between active disease in weight bearing joints
and vigorous physical activity, while all other associa-
tions between disease related factors and PA were insig-
nificant. In our group of patients 23 patients fulfilled the
criteria for remission, 20 still on medication and three
without. We found no difference in PA between patients
in remission and patients with active disease. Details are
given in Table 5.
In the subgroup “undifferentiated JIA” was only one
patient and this patient had a relatively low PA; omitting
this patient from the analysis of variance we found no
significant association between JIA subgroup and PA.
Discussion
We have found a significant difference, both in average
PA (cpm) and in the level of PA, between children and ad-
olescents with JIA and healthy schoolchildren (Table 3),
supporting our hypothesis that patients with JIA are less
physically active than their peers. We are not aware of
other publications reporting objectively measured physical
activity in children with JIA, but our findings are in ac-
cordance with a controlled cross sectional study by Lelie-
veld et al. [21] on physical activity in adolescents with JIA
making use of self-reporting in an activity diary. Even
though only 8 of the 30 included patients in that study
had active disease, adolescents with JIA spent significantly
longer time resting in bed and significantly shorter time
on activities of moderate and high intensity; no association
between PA and clinical disease activity or functional abil-
ity was found.
The difference in cpm and minutes per day spent on
PA between healthy children and children with JIA
(Table 3), may appear small, approximately 10 %; but an
inactive lifestyle in a child with a chronic illness like JIA
is likely to have a more permanent character than in a
healthy child and thus be more harmful to normal phys-
ical development. Physical activity was not assessed in a
recent study [22] reporting reduced aerobic capacity in
patients with both active and inactive JIA but physical
inactivity may have been a contributing factor. Unfortu-
nately, we were not able to assess aerobic capacity,
which is associated with PA, and presumably a param-
eter of higher prognostic value for general health related
outcome in adulthood, than an episodic measurement of
actual physical activity. It is noteworthy that only 61 %
of boys and 39 % of girls in the reference group (Table 4)
fulfilled the Danish Health Authorities’ guidelines for
daily physical activity in childhood in maintaining gen-
eral health. The small difference in PA between patients
with JIA and healthy children found in our study may
Table 3 Physical Activity in patients with JIA compared to healthy schoolchildren
Physical Activity (PA) Patients with JIA Age- and gender-matched, healthy schoolchildren p-valuea
133 In total 1692
Mean cpm 475.6 (SD 178.8) 522.7 0.0000018
Minutes per day with cpm >1500 67.9 (SD 32.3) 76.4 0.0000014
Minutes per day with cpm >2000 (MPA) 48.4 (SD 24.7) 52.8 0.00010
Minutes per day with cpm >3000 (HPA) 24.7 (SD16.3) 26.5 0.00015
PA values were log10 transformed and pairwise compared by The Related-Samples Wilcoxon Signed Rank Test (2-tailed, α = 0.05)
aComparison of the distributions of PA in patients with JIA and gender- and age-matched healthy schoolchildren
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thus have more serious consequences than the figures
suggest.
We used accelerometers in the assessment of PA in
order to obtain more reliable data than mere self-
reporting can yield. These motion sensors provide in-
formative data on the complex movements of children
and have been validated against methods for evaluating
energy expenditure in the body [9]. The large investiga-
tions on healthy schoolchildren using accelerometers
and well established international guidelines for inter-
pretation of the data provide useful references according
to age and gender. We asked the families to note time
spent on cycling and horseback riding and swimming
and we adjusted for swimming activity [23], but other
activities were generally of a short duration and did not
necessitate any corrections in the final assessment of the
child’s physical activity. Reason given for not wearing the
accelerometer was typically forgetfulness. We found only
a modest association between self-reported PA and ac-
celerometer measurements (data not shown).
PA is important for a healthy development and main-
tenance of all organs in the body as well as for acquiring
and maintaining cognitive and social skills. In the wake
of the decreasing physical demands in modern life style,
the incidence of premature cardiovascular and metabolic
diseases is rising internationally [24] but seem to begin
leveling off in western countries presumably due to
higher awareness of risk factors connected to lifestyle,
and better medication. A large European study on phys-
ical activity in healthy schoolchildren (EYHS) showed a
negative association between clustering of traditional
risk factors for development of cardiovascular disease
and levels of physical activity [8]. That investigation led
to a general recommendation from the Danish Health
Authorities [13] of a minimum of 1 h of moderate to vig-
orous PA per day, equivalent to more than >2000 cpm/
day in our study, and corresponding to a walking speed of
around 4 km/h. Only 19 % of the girls and 45 % of the
boys in our study met the goal.
Physical inactivity in children and young adults with
JIA may thus be an additional driver in the premature
development in adulthood of atherosclerosis, which may
be promoted by the chronic inflammation per se. Inter-
estingly Aulie et al. [25] in a controlled study of vascular
health in adults with persistently active JIA found an
association between decreased augmentation index, a
marker of arterial stiffness, and self-reported high phys-
ical activity, suggestive of a protective cardiovascular ef-
fect of high physical activity in patients with JIA. High
BMI is another traditional risk factor for premature de-
velopment of atherosclerosis, also associated with phys-
ical inactivity; the BMI of our patients was within the
normal range.
The reduced level of PA in JIA is not easily explained.
Except for an understandable negative association be-
tween vigorous physical activity and inflamed weight-
bearing joints, we found no association between objective
or subjective signs of disease activity, including remission,
and level or pattern of physical activity. This is also in ac-
cordance with the findings by Lelieveld et al. [21].
Only three of our patients were in remission off medi-
cation. This may explain why the level and pattern of PA
did not differ between those in remission and those with
active disease. The finding raises concern, however, re-
garding a possible continuation of a lifestyle initiated in
an active phase of a long lasting disease with no adjust-
ments parallel to improvement.
We did not assess fatigue specifically. An association
in patients with RA between higher level of physical ac-
tivity and reduced level of fatigue has been described by
Rongen et al. [26]. The fatigue had no relation to pain or
disability, disease activity, cognition or coping, but fa-
tigue could still be an inherent feature of inflammation,
not easily captured in our evaluation of disease activity.
Looking at patients with JIA, Ringold et al. [27] found a
significant association between CHAQ, pain, and fatigue
despite an overall low disease activity. In our study an
association between PA and pain was not found. The
pain scoring was, however, significantly higher than
would be expected looking at the physician’s global dis-
ease scoring. This discrepancy has been addressed in
several studies on pain in children with JIA [28–30].
Patients with JIA primarily need aggressive anti-
inflammatory treatment in order to avoid bone erosion
and destruction of joints, but when inflammation has
been curbed, a return to a normal healthy lifestyle
should be highly prioritized. As in the studies by Ringold
et al. [27] and Lelieveld et al. [21], the disease activity in
our patients was low, judged by objective signs and phy-
sician’s global VAS, and there is no reason to believe that
mere intensification of medication would lead to higher
level of PA.
Structured PA is added to conventional treatment of
patients with JIA in several intervention studies [31–33].
A significant positive effect on general function by the
end of the intervention was found in all studies. In the
study by Takken et al. [32] an effect was only seen for
the children with the poorest function at inclusion. In a
Cochrane review, Takken et al. [34] found no significant
Table 4 Percentage of participating patients fulfilling The
Danish Health Authorities’ guidelines [13] for daily physical
activity (PA) in childhood of more than 60 min a day of
moderate physical activity (MPA)
Percentage of boys with JIA/percentage of boys in the reference
group: 45/61
Percentage of girls with JIA/Percentage of girls in the reference
group: 19/39
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support for the notion that adding PA to conventional
medical treatment had a positive long-term effect on
functional ability, quality of life, aerobic capacity or pain,
although the reported short-term effects were promising.
Long-lasting changes in a child’s lifestyle probably re-
quire a multidisciplinary approach built upon an idea of
“self-efficacy” and addressing the complex and many-
sided phenomenon of pain may be crucial. This must
necessarily also involve the parents.
Importantly, Takken et al. in their review found no ad-
verse effect of structured PA for children with JIA.
The strength of the present study is the relatively high
number of participating children and adolescents with
JIA with a well described disease not significantly
Table 5 Disease characteristics in relation to level and pattern of physical activity
Mean cpm Minutes per day spent at >1500 cpm Minutes per day spent at >3000 cpm (HPA)
Subgroup of JIA F = 0.794 F = 0.927 F = 1.349
Analysis of variance p = 0.531 p = 0.450 p = 0.255
Remission vs non-remission F = 0.057 F = 0.369 F = 0.148
Analysis of variance p = 0.811 p = 0.544 p = 0.701
Treatmenta F = 0.502 F = 1.127 F = 0.199
Analysis of variance p = 0.607 p = 0.328 p = 0.820
Disease duration β = 0.27 β = 0.005 β = 0.077
Linear regression p = 0.758 p = 0.957 p = 0.376
Number of active joints β = − 0.104 β = − 0.119 β = − 0.153
Linear regression p = 0.235 p = 0.171 p = 0.078
Physician global VAS rho = − 0.60 rho = − 0.062 rho = − 0.105
Spearman correlation p = 0.489 p = 0.476 p = 0.228
Patient/parent global VAS rho = − 0.072 rho = − 0.062 rho = − 0.018
Spearman correlation p = 0.416 p = 0.487 p = 0.841
CRP β = − 0.050 β = − 0.079 β = − 0.149
Linear regression p = 0.591 p = 0.393 p = 0.107
JADAS 27 β = − 0.085 β = − 0.093 β = − 0.134
Linear regression p = 0.340 p = 0.294 p = 0.144
Number of active weight-bearing joints β = − 0.074 β = − 0.069 β = − 0.213
Linear regression p = 0.400 p = 0.432 p = 0.014b
Number of joints with limited motion only β = 0.054 β = 0.073 β = 0.105
Linear regression p = 0.535 p = 0.405 p = 0.229
Tendinitis and/or enthesitis 473 vs. 455 68 vs. 63 27 vs. 26
T-test p = 0.600 p = 0.402 p = 0.330
Pain VAS rho = − 0.018 rho = − 0.002 rho = − 0.026
Spearman correlation p = 0.841 p = 0.985 p = 0.775
CHAQ rho = − 0.066 rho = − 0.065 rho = − 0.086
Spearman correlation p = 0.457 p = 0.465 p = 0.334
aTreatment: either only intra-articular steroid injection or only methotrexate or biologicals with or without methotrexate
bSignificance (p) is given as two-tailed and α selected as 0.05
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different in disease characteristics from the rest of the
patients with JIA living in the eastern part of Denmark.
The reason given for not participating was not active
disease but unwillingness to participate in yet another
project during the course of the disease. This is also
reflected in the significant difference in disease duration
found between the fully participating patients and those
not willing to wear the accelerometer.
The large reference material and the reliable objective
way of assessing daily PA are excellent bases for our study.
In an investigation of a cross-sectional design only as-
sociations can be pointed out; causal pathways cannot
be shown. We have not measured aerobic capacity; this
is a weakness as aerobic capacity presumably is of
greater prognostic value for continuing health than PA
itself. We have not in our study assessed psychological
or social factors, school attendance, disease beliefs, and
beliefs regarding the benefits of PA, neither in the pa-
tients nor the parents. Understanding of these complex
issues are of outmost importance for any kind of inter-
vention in lifestyle.
We have not looked for special characteristics in those
participants in the study able to live a physically and so-
cially active life in spite of their chronic disease; such
studies might provide further insight.
Conclusion
The children and young adults with JIA who partici-
pated in our study are on average less physically active
than their healthy peers, and less active than is recom-
mended for general health by the Danish Health Author-
ities. This is not explained by objective, disease related
factors and is thus not likely to be remedied by a more
aggressive anti-inflammatory treatment. The well-known
increased risk for cardiovascular and metabolic diseases
related to an inactive lifestyle may thus reduce the pro-
spect of a long healthy life without functional disability
which our modern effective anti-inflammatory medicine
offers. Incorporation in the medical treatment schedule of
a program for regular physical exercise among peers may
well benefit many of the patients. We speculate that we,
by addressing the complex and multifaceted phenomenon
of pain, may gain the patients’ attention also regarding
positive changes in lifestyle.
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